SAB Biotherapeutics, Inc. (SABS) SEC filings

SABS SEC filings moved a median of -0.19% by the close. SABS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SABS overview →

71 measured SABS SEC filing events.

Where these SABS SEC filings landedvs 70 measured SABS SEC filing reactions
SABS SEC filingMiddle 50% · -3.56% to +2.26%Zero: 0.00%Median: -0.19%Median -0.19%-5.00%0+5.00%
Middle 50% of SABS SEC filing reactions-3.56% to +2.26%
Median reaction (to close)-0.19%
Measured reactions70
Point-in-time · zero look-ahead

Half of the 70 SABS SEC filing events with a measured close landed between -3.56% and +2.26%; 43% closed up.

DateHeadlineEvent5-minTo close
Form 8-K SAB Biotherapeutics, For: Oct 13SEC filing · Form 8-K-0.35%-5.63%
Form 10-Q SAB Biotherapeutics, For: Jun 30SEC filing · Form 10-Q-0.27%+2.39%
Form 8-K SAB Biotherapeutics, For: Jul 07SEC filing · Form 8-K-6.91%-0.26%
Form 8-K SAB Biotherapeutics, For: Jun 18SEC filing · Form 8-K-1.13%-1.75%
Form 10-Q SAB Biotherapeutics, For: Mar 31SEC filing · Form 10-Q-2.63%-4.74%
Form 8-K SAB Biotherapeutics, For: Apr 28SEC filing · Form 8-K-0.55%+0.55%
Form DEF 14A SAB Biotherapeutics, For: Jun 18SEC filing · Form DEF+2.02%-6.72%
Form 8-K SAB Biotherapeutics, For: Apr 22SEC filing · Form 8-K+0.26%+3.64%
Form S-8 SAB Biotherapeutics,SEC filing · Form S-8+0.00%+0.78%
Form 8-K SAB Biotherapeutics, For: Mar 17SEC filing · Form 8-K+2.17%+2.44%
Form 8-K SAB Biotherapeutics, For: Mar 10SEC filing · Form 8-K+0.25%+1.24%
Form 10-K SAB Biotherapeutics, For: Dec 31SEC filing · Form 10-K+0.25%+1.24%
Form 8-K SAB Biotherapeutics, For: Jan 12SEC filing · Form 8-K+0.27%+5.91%
Form EFFECT SAB Biotherapeutics,SEC filing · Form EFFECT-3.68%-5.39%
Form 8-K SAB Biotherapeutics, For: Jan 05SEC filing · Form 8-K-0.26%+2.85%
Form S-3 SAB Biotherapeutics,SEC filing · Form S-3-0.56%+5.31%
Form 8-K SAB Biotherapeutics, For: Dec 29SEC filing · Form 8-K+0.00%+4.72%
Form S-8 SAB Biotherapeutics,SEC filing · Form S-8-0.75%-0.50%
Form 10-Q SAB Biotherapeutics, For: Sep 30SEC filing · Form 10-Q+2.31%+6.93%
Form EFFECT SAB Biotherapeutics,SEC filing · Form EFFECT-1.00%-0.50%
Form 8-K SAB Biotherapeutics, For: Sep 30SEC filing · Form 8-K-1.00%-0.50%
Form 8-K SAB Biotherapeutics, For: Sep 26SEC filing · Form 8-K+1.76%-4.41%
Form S-3/A SAB Biotherapeutics,SEC filing · Form S-3-2.02%-8.50%
Form S-3 SAB Biotherapeutics,SEC filing · Form S-3+2.36%+9.43%
Form DEF 14A SAB Biotherapeutics, For: Sep 26SEC filing · Form DEF+6.93%+2.91%
Form PRE 14A SAB Biotherapeutics, For: Aug 19SEC filing · Form PRE-0.50%—
Form 10-Q SAB Biotherapeutics, For: Jun 30SEC filing · Form 10-Q+2.28%+1.83%
Form D SAB Biotherapeutics,SEC filing · Form D+0.00%-2.67%
Form 8-K SAB Biotherapeutics, For: Jul 21SEC filing · Form 8-K+15.78%-22.64%
Form 8-K SAB Biotherapeutics, For: Jul 17SEC filing · Form 8-K+0.00%-8.54%
Form DEF 14A SAB Biotherapeutics, For: Jul 17SEC filing · Form DEF—-3.13%
Form 10-Q SAB Biotherapeutics, For: Mar 31SEC filing · Form 10-Q—+4.07%
Form S-8 SAB Biotherapeutics,SEC filing · Form S-8+0.00%-1.74%
Form 10-K SAB Biotherapeutics, For: Dec 31SEC filing · Form 10-K—-6.21%
Form 8-K SAB Biotherapeutics, For: Jan 30SEC filing · Form 8-K+0.47%-0.94%
Form 8-K SAB Biotherapeutics, For: Jan 28SEC filing · Form 8-K-13.39%-18.50%
Form 10-Q SAB Biotherapeutics, For: Sep 30SEC filing · Form 10-Q+2.53%-17.21%
Form 8-K SAB Biotherapeutics, For: Sep 09SEC filing · Form 8-K—+4.94%
Form S-8 SAB Biotherapeutics,SEC filing · Form S-8+0.00%-3.77%
Form 10-Q SAB Biotherapeutics, For: Jun 30SEC filing · Form 10-Q—-12.26%
Form 8-K SAB Biotherapeutics, For: Jul 26SEC filing · Form 8-K+0.00%-3.64%
Form 8-K SAB Biotherapeutics, For: Jun 27SEC filing · Form 8-K+3.98%+6.16%
Form 8-K SAB Biotherapeutics, For: May 26SEC filing · Form 8-K—+0.38%
Form DEF 14A SAB Biotherapeutics, For: May 22SEC filing · Form DEF—+0.38%
Form 8-K SAB Biotherapeutics, For: May 21SEC filing · Form 8-K+6.00%-3.00%
Form 10-Q SAB Biotherapeutics, For: Mar 31SEC filing · Form 10-Q+6.00%-3.00%
Form NT 10-Q SAB Biotherapeutics, For: Mar 31SEC filing · Form NT-1.74%-3.97%
Form 8-K SAB Biotherapeutics, For: May 03SEC filing · Form 8-K+0.00%+0.00%
Form 8-K SAB Biotherapeutics, For: Apr 12SEC filing · Form 8-K+0.00%-1.22%
Form 10-K SAB Biotherapeutics, For: Dec 31SEC filing · Form 10-K+0.00%-4.88%
Form 8-K SAB Biotherapeutics, For: Mar 29SEC filing · Form 8-K+0.00%-4.88%
Form 8-K SAB Biotherapeutics, For: Mar 05SEC filing · Form 8-K-0.56%+1.85%
Form S-8 SAB Biotherapeutics,SEC filing · Form S-8-0.20%+1.84%
Form 8-K SAB Biotherapeutics, For: Jan 30SEC filing · Form 8-K—+1.71%
Form 8-K SAB Biotherapeutics, For: Jan 26SEC filing · Form 8-K-8.74%+11.34%
Form 8-K SAB Biotherapeutics, For: Jan 23SEC filing · Form 8-K-0.17%+1.62%
Form 8-K SAB Biotherapeutics, For: Jan 19SEC filing · Form 8-K+0.17%-1.52%
Form 8-K SAB Biotherapeutics, For: Jan 02SEC filing · Form 8-K-2.73%-0.12%
Form DEF 14A SAB Biotherapeutics, For: Dec 18SEC filing · Form DEF+1.30%-3.04%
Form PRE 14A SAB Biotherapeutics, For: Dec 08SEC filing · Form PRE+0.00%-5.09%
Form 8-K SAB Biotherapeutics, For: Nov 29SEC filing · Form 8-K+0.00%-3.33%
Form EFFECT SAB Biotherapeutics,SEC filing · Form EFFECT+0.00%-3.33%
Form 8-K SAB Biotherapeutics, For: Nov 22SEC filing · Form 8-K+0.00%-1.10%
Form 8-K SAB Biotherapeutics, For: Nov 14SEC filing · Form 8-K+0.00%+12.21%
Form S-3/A SAB Biotherapeutics,SEC filing · Form S-3+0.00%+12.21%
Form 8-K/A SAB Biotherapeutics, For: Sep 29SEC filing · Form 8-K+0.00%+0.00%
Form DEFA14A SAB Biotherapeutics,SEC filing · Form DEFA14A+0.00%+0.00%
Form 10-Q SAB Biotherapeutics, For: Sep 30SEC filing · Form 10-Q—+0.00%
Form S-3 SAB Biotherapeutics,SEC filing · Form S-3+0.00%+1.80%
Form DEF 14A SAB Biotherapeutics, For: Oct 30SEC filing · Form DEF+3.29%+3.29%
Form 8-K SAB Biotherapeutics, For: Oct 23SEC filing · Form 8-K+0.00%+2.55%
That’s how SABS usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More SABS: earnings → · analyst actions → · SABS overview →